Rosalind Advisors, Inc. - Feb 13, 2025 SCHEDULE 13G/A Report for Trevi Therapeutics, Inc. Common Shares (TRVI)

Filing Manager
Rosalind Advisors, Inc.
Reporting Manager
Rosalind Advisors, Inc.
Security
Trevi Therapeutics, Inc. Common Shares
Symbol
TRVI
Shares outstanding
88.5M shares
Disclosed Ownership
1.06M shares
Ownership
1.2%
Form type
SCHEDULE 13G/A
Date filed
2/13/2025, 01:41 PM
Date of event
Feb 13, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rosalind Advisors, Inc. 1.2% 1.06M 0 1.06M Steven Salamon President
SALAMON STEVEN A J 1.2% 1.06M 0 1.06M Steven Salamon Steven Salamon
Aharon Gil 1.2% 1.06M 0 1.06M Gil Aharon Gil Aharon
Rosalind Master Fund L.P. 1.2% 1.06M 0 1.06M Mike McDonald Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)